11:04 AM EST, 11/22/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending modestly higher late Friday morning, rising 0.19% to 1,316.54 on the S&P Europe Select ADR Index, which is up approximately 1.2% for the week.

From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and medical device maker EDAP TMS ( EDAP ) , which rose 3.6% and 2.6%, respectively. They were followed by internet browser company Opera (OPRA) and pharmaceutical company Ascendis Pharma ( ASND ) , which were up 2.1% each.

The decliners from continental Europe were led by biopharmaceutical company Genfit ( GNFT ) and financial services company Banco Santander (SAN), which dropped 4.8% and 3.9%, respectively. They were followed by financial services companies ING (ING) and Banco Bilbao Vizcaya Argentaria ( BBVA ) , which fell 2.7% and 2%, respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company Amarin ( AMRN ) , which climbed 13% and 5.6% higher, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and pharmaceutical company AstraZeneca ( AZN ) , which increased 5.5% and 2.9%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and TC Biopharm ( TCBP ) , which lost 12% and 3.9%, respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which were down 3.1% and 2.5%, respectively.